Laboratorios Farmaceuticos Rovi, S.A.
LABFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,486 | $2,502 | $2,552 | $3,350 |
| - Cash | $27 | $25 | $125 | $99 |
| + Debt | $114 | $65 | $72 | $73 |
| Enterprise Value | $4,573 | $2,542 | $2,499 | $3,324 |
| Revenue | $764 | $830 | $818 | $649 |
| % Growth | -7.9% | 1.4% | 26.1% | – |
| Gross Profit | $468 | $483 | $512 | $380 |
| % Margin | 61.2% | 58.3% | 62.7% | 58.6% |
| EBITDA | $200 | $238 | $271 | $197 |
| % Margin | 26.1% | 28.7% | 33.2% | 30.3% |
| Net Income | $137 | $170 | $200 | $153 |
| % Margin | 17.9% | 20.5% | 24.4% | 23.6% |
| EPS Diluted | 2.67 | 3.2 | 3.73 | 2.76 |
| % Growth | -16.6% | -14.2% | 35.1% | – |
| Operating Cash Flow | $138 | $113 | $238 | $149 |
| Capital Expenditures | -$62 | -$55 | -$51 | -$41 |
| Free Cash Flow | $76 | $58 | $186 | $109 |